Under construction – not a live service
Sign in
Taking people in AustriaNo phase

Records outcomes and side effects of proton and carbon ion radiation therapy

Records patients with tumors treated with proton or carbon ion radiation at MedAustron.

Plain-language title generated from the registry record
Registry title: Ion Therapy Patient Registry

Key facts

Where
Wiener Neustadt, AustriaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for patients with a tumor who are treated with ion beam therapy at MedAustron. Their treatment data and side effects are recorded.

Sex
All sexes can join.
Disease stage
Tumor disease treated with ion beam therapy at MedAustron.

Main reasons for not taking part

  • Other illnesses that put treatment delivery at risk
  • Other illnesses that put taking part in the study at risk

Read by machine on 9 November 2026.

Where in Austria

  • EBG MedAustron GmbHWiener Neustadt, AustriaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
EBG MedAustron GmbH
Trial code
NCT03049072
Record updated
23 March 2026
Original description
The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.Read full original descriptionShow less

A Prospective Registry Study to Record Clinical Results and Side Effects of Ion Beam Therapy at MedAustron

The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.

Inclusion: Patients with tumor disease treated with ion beam therapy at MedAustron; Signed informed consent form.

Exclusion: Comorbidities endangering treatment delivery or study compliance.

ClinicalTrials.gov NCT03049072